Investigation Overview
September 1, 2017 (Shareholders Foundation) - An investigation on behalf of investors of Acorda Therapeutics Inc (NASDAQ:ACOR) shares over potential securities laws violations by Acorda Therapeutics and certain of its directors and officers in connection with certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchasers...
You must register (for free) or login to view the entire investigation.